Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Cannabidiol for Anxiety

NCT02548559 is registered in ClinicalTrials.gov with Staci Gruber, Ph.D. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02548559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Cannabidiol for Anxiety
Lead sponsor
Staci Gruber, Ph.D.
Phase
Phase 2
Overall status
Completed
Start date
August 14, 2018
Completion date
March 13, 2025
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety